Literature DB >> 7271395

Vascular activity of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist.

J M Van Nueten, R Xhonneux, P M Vanhoutte, P A Janssen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7271395

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  2 in total

1.  In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.

Authors:  S Conolan; M J Quinn; D A Taylor
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

2.  Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.

Authors:  Ying Zhu; Kun-Bin Ke; Zhong-Kun Xia; Hong-Jian Li; Rong Su; Chao Dong; Feng-Mei Zhou; Lin Wang; Rong Chen; Shi-Guo Wu; Hui Zhao; Peng Gu; Kwong-Sak Leung; Man-Hon Wong; Gang Lu; Jian-Ying Zhang; Bing-Hua Jiang; Jian-Ge Qiu; Xi-Nan Shi; Marie Chia-Mi Lin
Journal:  Mol Med       Date:  2021-02-12       Impact factor: 6.354
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.